Immunotherapy Combinations on the Horizon for Ovarian Cancer – Targeted Oncology
Targeted Oncology |
Immunotherapy Combinations on the Horizon for Ovarian Cancer
Targeted Oncology Despite prior studies failing to show benefit with the use of single-agent immunotherapy with checkpoint inhibitors, researchers are continuing to explore this area. There are currently 5 phase III clinical trials evaluating checkpoint blockade in … |
